TRIP-1 via AKT modulation drives lung fibroblast/myofibroblast trans-differentiation

BACKGROUND: Myofibroblasts are the critical effector cells in the pathogenesis of pulmonary fibrosis which carries a high degree of morbidity and mortality. We have previously identified Type II TGFβ receptor interacting protein 1 (TRIP-1), through proteomic analysis, as a key regulator of collagen...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyp, Michael F, Navarro, Angels, Rezaiekhaligh, Mohammad H, Perez, Ricardo E, Mabry, Sherry M, Ekekezie, Ikechukwu I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946032/
https://www.ncbi.nlm.nih.gov/pubmed/24528651
http://dx.doi.org/10.1186/1465-9921-15-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946032/
https://www.ncbi.nlm.nih.gov/pubmed/24528651
http://dx.doi.org/10.1186/1465-9921-15-19

Ejemplares similares